Paid Clinical Trials in Washington

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing 41 – 60 of 160 results

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

by CTG

in Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Bone, Localized Renal Pelvis and Ureter Urothelial Carcinoma, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma

Other

Washington

Deadline:

01/31/2029

Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth

by CTG

in Child Behavior, Parenting, Parent-Child Relations, Child Maltreatment

Other

Washington

Deadline:

04/12/2028

REACT-01: Reversing Autoimmunity Through Cell Therapy

by CTG

in Systemic Lupus Erythematosus

Other

Washington

Deadline:

10/01/2041

Transcutaneous Stimulation for Neurological Populations

by CTG

in Cerebral Palsy, Neurological Disorder

Other

Washington

Deadline:

12/01/2027

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm

Other

Washington

Deadline:

03/31/2026

A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma

by CTG

in Leukemia

Other

Washington

Deadline:

07/01/2035

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

by CTG

in General Health, Wellness

Other

Washington

Deadline:

07/23/2028

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

by CTG

in Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia, Anaplastic Large Cell Lymphoma, Adult Diffuse Large Cell Lymphoma

Other

Washington

Deadline:

01/10/2028

A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma

by CTG

in Osteosarcoma

Other

Washington

Deadline:

05/01/2040

Comparison of Outcomes of Management of Bowel Obstruction Pilot Study

by CTG

in Adhesive Small Bowel Obstruction

Other

Washington

Deadline:

03/01/2026

Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke

by CTG

in Chronic Stroke, Stroke, Ischemic

Other

Washington

Deadline:

12/31/2026

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

by CTG

in HIV

Other

Washington

Deadline:

06/30/2027

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

by CTG

in Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Acute Leukemia of Ambiguous Lineage

Other

Washington

Deadline:

06/30/2029

An AHEI Dietary Intervention to Reduce Pain in Women With Endometriosis

by CTG

in Endometriosis

Other

Washington

Deadline:

02/28/2026

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

by CTG

in Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Indeterminate Colitis, Functional Abdominal Pain Syndrome

Other

Washington

Deadline:

01/01/2030

Effect of Estrogen Treatment on Drug Metabolism and Transport

by CTG

in Transgender Persons

Other

Washington

Deadline:

06/30/2026

Washington State Driving Intervention Research Study

by CTG

in Driving Behavior

Other

Washington

Deadline:

02/01/2027

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

by CTG

in Non-small Cell Lung Cancer

Other

Washington

Deadline:

03/30/2026

A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery

by CTG

in Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage IVA Lip and Oral Cavity Cancer AJCC v8

Other

Washington

Deadline:

01/20/2027

Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

by CTG

in Chronic Pancreatitis, Pancreatitis, Acute Recurrent Pancreatitis

Other

Washington

Deadline:

09/30/2026

Load more All clinical trials loaded.